Ubs Group Ag Dare Bioscience, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$0.28 - $0.61 $27,584 - $60,094
98,516 Added 19703.2%
99,016 $33,000
Q1 2024

May 13, 2024
SELL
$0.31 - $0.57 $2,511 - $4,617
-8,100 Reduced 94.19%
500 $0
Q4 2023

Feb 09, 2024
BUY
$0.29 - $0.53 $2,349 - $4,293
8,100 Added 1620.0%
8,600 $2,000
Q1 2023

May 12, 2023
SELL
$0.87 - $1.36 $23,855 - $37,291
-27,420 Reduced 98.21%
500 $0
Q4 2022

Feb 08, 2023
SELL
$0.82 - $12.6 $23,429 - $360,007
-28,572 Reduced 50.58%
27,920 $23,000
Q3 2022

Nov 10, 2022
BUY
$1.04 - $12.48 $58,231 - $698,780
55,992 Added 11198.4%
56,492 $57,000
Q2 2022

Aug 10, 2022
SELL
$0.94 - $1.76 $4,479 - $8,386
-4,765 Reduced 90.5%
500 $1,000
Q1 2022

May 16, 2022
SELL
$1.42 - $2.09 $14,008 - $20,617
-9,865 Reduced 65.2%
5,265 $8,000
Q4 2021

Feb 14, 2022
BUY
$1.42 - $2.13 $20,774 - $31,161
14,630 Added 2926.0%
15,130 $30,000
Q3 2021

Nov 15, 2021
SELL
$1.42 - $2.0 $14,856 - $20,924
-10,462 Reduced 95.44%
500 $1,000
Q2 2021

Aug 13, 2021
BUY
$1.21 - $1.89 $12,659 - $19,773
10,462 Added 2092.4%
10,962 $21,000
Q2 2020

Jul 31, 2020
SELL
$0.84 - $1.11 $31,921 - $42,182
-38,002 Reduced 98.7%
500 $0
Q1 2020

May 01, 2020
BUY
$0.79 - $1.7 $30,416 - $65,453
38,502 New
38,502 $32,000
Q3 2019

Nov 14, 2019
SELL
$0.74 - $0.87 $93 - $109
-126 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$0.79 - $1.66 $5,646 - $11,864
-7,147 Reduced 98.27%
126 $0
Q1 2019

May 14, 2019
BUY
$0.73 - $2.1 $1,637 - $4,710
2,243 Added 44.59%
7,273 $10,000
Q4 2018

Feb 14, 2019
BUY
$0.63 - $1.12 $2,979 - $5,297
4,730 Added 1576.67%
5,030 $4,000
Q3 2018

Nov 14, 2018
SELL
$0.92 - $1.43 $5,123 - $7,963
-5,569 Reduced 94.89%
300 $0
Q2 2018

Aug 14, 2018
BUY
$0.76 - $1.48 $4,057 - $7,901
5,339 Added 1007.36%
5,869 $7,000
Q1 2018

May 15, 2018
SELL
$0.83 - $2.79 $3,082 - $10,362
-3,714 Reduced 87.51%
530 $0
Q4 2017

Feb 14, 2018
SELL
$2.16 - $3.35 $995 - $1,544
-461 Reduced 9.8%
4,244 $9,000
Q3 2017

Nov 14, 2017
BUY
$2.63 - $3.52 $12,374 - $16,561
4,705
4,705 $14,000

Others Institutions Holding DARE

# of Institutions
3
Shares Held
267K
Call Options Held
0
Put Options Held
0
View Full List

About Dare Bioscience, Inc.

DARE Quotes by TradingView
  • Ticker DARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,820,896
  • Market Cap $271M
  • Description
  • Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...
More about DARE
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email